Genetic CRC risk likely mediated by differential adenoma risk

Genetic CRC risk likely mediated by differential adenoma risk
Much of the genetic risk for colorectal cancer in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

(HealthDay)—Much of the genetic risk for colorectal cancer (CRC) in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

Luis G. Carvajal-Carmona, Ph.D., from the University of Oxford in the United Kingdom, and colleagues analyzed genotype data from 1,755 adenoma cases and 3,976 controls with no colorectal disease for 18 CRC single-nucleotide polymorphisms (SNPs).

The researchers found that eight of 18 known CRC-associated SNPs (rs10936599, rs6983267, rs10795668, rs3802842, rs4444235, rs1957636, rs4939827, and rs961253) were over-represented in CRC-free patients with adenomas, compared with controls. There was no significant association with adenoma risk with the other CRC-associated SNPs (rs6691170, rs6687758, rs16892766, rs7136702, rs11169552, rs4779584, rs9929218, rs10411210, rs4813802, and rs4925386).

" to CRC in the general population is likely to be mediated in part by predisposition to ," the authors write. "In principle, especially if further studies can assign SNPs as adenoma-predisposing, carcinoma-predisposing, or both, such variation could be used to modulate population-based CRC-prevention measures, in a way analogous to the different
methods of prophylaxis used for familial adenomatous polyposis and Lynch syndrome."

Pfizer and Merck both contributed funding to this research.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Reduced efficacy for CRC screenings done by non-GI docs

Jun 22, 2012

(HealthDay) -- Having interval colorectal cancer (CRC) colonoscopy screenings performed by nongastroenterologists compared with gastroenterologists (GIs) results in a noticeable reduction in the long-term ...

Recommended for you

The fine line between breast cancer and normal tissues

5 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

6 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

8 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

10 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments